Am J Clin Oncol
- MISTRY T, Nath A, Pal R, Ghosh S, et al
Emerging Futuristic Targeted Therapeutics: A Comprising Study Towards a New Era
for the Management of TNBC.
Am J Clin Oncol. 2024;47:132-148.
Am J Epidemiol
- CHANG CJ, Ish JL, Chang VC, Daniel M, et al
Exposure to Per- and Polyfluoroalkyl Substances and Breast Cancer Risk: A
Systematic Review and Meta-analysis of Epidemiologic Studies.
Am J Epidemiol. 2024 Feb 23:kwae010. doi: 10.1093.
Am J Surg
- CORTINA CS, Kong AL
Should surgeons reconsider the role of intraoperative sentinel lymph node
evaluation for premenopausal breast cancer patients in the era of RxPONDER?
Am J Surg. 2024 Feb 17:S0002-9610(24)00123-5. doi: 10.1016/j.amjsurg.2024.
- ESCANDON JM, Langstein HN, Christiano JG, Aristizabal A, et al
Latissimus dorsi flap with immediate fat transfer (LIFT) for autologous breast
reconstruction: Single institution experience.
Am J Surg. 2024;228:185-191.
Ann Oncol
- GENNARI A, Brain E, De Censi A, Nanni O, et al
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic
breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET.
Ann Oncol. 2024 Feb 27:S0923-7534(24)00057-7. doi: 10.1016/j.annonc.2024.
Ann Surg Oncol
- JAKUB JW, Advani P, Maxwell R, Vallow L, et al
SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We
Ready to Change the Tune of Our Breast Cancer Practice?
Ann Surg Oncol. 2024 Feb 28. doi: 10.1245/s10434-024-15111.
- COSTARELLI L, Arienzo F, Broglia L, La Pinta M, et al
Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After
Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management
Changes?
Ann Surg Oncol. 2024 Mar 1. doi: 10.1245/s10434-024-15052.
Anticancer Res
- SHIN JK, Kim HS, Yoon S
Co-treatment With Aripiprazole and Vincristine Sensitizes
P-Glycoprotein-Overexpressing Drug-resistant MCF-7/ADR Breast Cancer Cells.
Anticancer Res. 2024;44:1051-1062.
- JANG SY, Kim J, Hong E, Yang YJ, et al
Phloretin Inhibits the Proliferation of Breast Cancer Cells Through the
Down-regulation of Estrogen Receptor alpha.
Anticancer Res. 2024;44:1109-1120.
- COLLERY P, Prunier C, Dosda E, Viallet J, et al
Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast
Cancer Chicken Embryo Model.
Anticancer Res. 2024;44:941-951.
- YANG DK, Tungalag T, Lee SJ, Kim SJ, et al
Methyl Jasmonate-induced Increase in Intracellular Magnesium Promotes Apoptosis
in Breast Cancer Cells.
Anticancer Res. 2024;44:1087-1095.
Breast Cancer
- WONG HH, Cojocaru E, Watkins J, James S, et al
Radiation-induced angiosarcoma of the breast: retrospective analysis at a
regional treatment centre.
Breast Cancer. 2024;31:272-282.
- WU X, Gui Y, Liu J, Li S, et al
Patient-reported outcomes of mesh in minimally invasive
(laparoscopic/robot-assisted) immediate subpectoral prosthesis breast
reconstruction: a retrospective study.
Breast Cancer. 2024;31:243-251.
- AOYAMA Y, Hoshino E, Shimomura A, Shimizu C, et al
Reliability and validity of the Japanese version of the Chemotherapy-induced
Alopecia Distress Scale.
Breast Cancer. 2024;31:234-242.
- CHEN BF, Tsai YF, Lien PJ, Lin YS, et al
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers
using a comprehensive genomic profiling assay in Taiwan.
Breast Cancer. 2024;31:217-227.
- PARIJA M, Prakash S, Krishna BM, Dash S, et al
SIRT1 mediates breast cancer development and tumorigenesis controlled by
estrogen-related receptor beta.
Breast Cancer. 2024 Feb 29. doi: 10.1007/s12282-024-01555.
- KASAHARA M, Kanematsu S, Tanaka Y, Okazaki S, et al
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a
comparison with stereotactic vacuum assisted biopsy.
Breast Cancer. 2024;31:329-334.
- NAKAMURA A, Ohnuki K, Takahashi H, Usami S, et al
The effects of breast density on the benefits of mammograms with adjunctive
ultrasonography in breast screening.
Breast Cancer. 2024;31:228-233.
Breast Cancer (Auckl)
- PREMJI SK, O'Sullivan CC
Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging
Therapeutic Options.
Breast Cancer (Auckl). 2024;18:11782234241234418.
Breast Cancer Res
- SONG T, Zhang H, Zhao Q, Hu Z, et al
Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in
estrogen receptor-positive breast cancer overcomes tamoxifen resistance.
Breast Cancer Res. 2024;26:33.
- EDWARDS CM, Kane JF, Smith JA, Grant DM, et al
PTHrP intracrine actions divergently influence breast cancer growth through p27
and LIFR.
Breast Cancer Res. 2024;26:34.
- SHATSKY RA, Batra-Sharma H, Helsten T, Schwab RB, et al
A phase 1b study of zilovertamab in combination with paclitaxel for locally
advanced/unresectable or metastatic Her2-negative breast cancer.
Breast Cancer Res. 2024;26:32.
- JUNG M, Song SG, Cho SI, Shin S, et al
Augmented interpretation of HER2, ER, and PR in breast cancer by artificial
intelligence analyzer: enhancing interobserver agreement through a reader study
of 201 cases.
Breast Cancer Res. 2024;26:31.
Breast Cancer Res Treat
- VOETS MM, Hassink NS, Veltman J, Slump CH, et al
Opportunities for personalised follow-up in breast cancer: the gap between daily
practice and recurrence risk.
Breast Cancer Res Treat. 2024 Feb 26. doi: 10.1007/s10549-024-07246.
- HOSSEINI Y, Hadi Sichani P, Moslemi E, Nouri M, et al
Pro-vegetarian dietary pattern and risk of breast cancer: a case-control study.
Breast Cancer Res Treat. 2024 Feb 28. doi: 10.1007/s10549-024-07243.
- DOUBBLESTEIN D, Koehler L, Anderson E, Scheiman N, et al
Development of a core outcome set for breast cancer-related lymphedema: a Delphi
study.
Breast Cancer Res Treat. 2024 Feb 29. doi: 10.1007/s10549-024-07262.
- WU Y, Li Z, Lee AV, Oesterreich S, et al
Liver tropism of ER mutant breast cancer is characterized by unique molecular
changes and immune infiltration.
Breast Cancer Res Treat. 2024 Mar 1. doi: 10.1007/s10549-024-07255.
Breast J
- SELAMIOGLU E, Agdogan O
Mammoplasty Using Modified Superomedial Pedicle Technique in Severely Macromastia
and Ptotic Breasts.
Breast J. 2024;2024:7635485.
Cancer
- ZHENG Q, Yan H, He Y, Wang J, et al
An ultrasound-based nomogram for predicting axillary node pathologic complete
response after neoadjuvant chemotherapy in breast cancer: Modeling and external
validation.
Cancer. 2024 Mar 1. doi: 10.1002/cncr.35248.
- HOU X, Li X, Han Y, Xu H, et al
Triple-negative breast cancer survival prediction using artificial intelligence
through integrated analysis of tertiary lymphoid structures and tumor budding.
Cancer. 2024 Feb 29. doi: 10.1002/cncr.35261.
- NIERENGARTEN MB
FDA approves capivasertib with fulvestrant for breast cancer.
Cancer. 2024;130:835-836.
Cancer Chemother Pharmacol
- MITTRA A, Coyne GHOS, Zlott J, Kummar S, et al
Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in
patients with BRCA-mutated advanced solid tumors.
Cancer Chemother Pharmacol. 2024;93:177-189.
Cancer Epidemiol Biomarkers Prev
- FARBER R, Houssami N, McGeechan K, Barratt A, et al
Breast cancer stage and size detected with film versus digital mammography in New
South Wales, Australia: a population-based study using routinely collected data.
Cancer Epidemiol Biomarkers Prev. 2024.
Cancer Lett
- MADORSKY ROWDO FP, Xiao G, Khramtsova GF, Nguyen J, et al
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are
sensitive to synergistic combination PARP inhibitor treatment.
Cancer Lett. 2024;584:216608.
- HAN BY, Chen C, Luo H, Lin CJ, et al
Clinical sequencing defines the somatic and germline mutation landscapes of
Chinese HER2-Low Breast Cancer.
Cancer Lett. 2024 Feb 23:216763. doi: 10.1016/j.canlet.2024.216763.
- SUN J, Du R, Li X, Liu C, et al
CD63(+) cancer-associated fibroblasts confer CDK4/6 inhibitor resistance to
breast cancer cells by exosomal miR-20.
Cancer Lett. 2024 Feb 23:216747. doi: 10.1016/j.canlet.2024.216747.
Clin Breast Cancer
- REYES A, Sun L, Ha R, Desperito E, et al
A Comprehensive Assessment of Radial Scars on Core Needle Biopsy in Patients with
or without Breast Cancer: Upgrade Rate and Implications on Management.
Clin Breast Cancer. 2024 Feb 1:S1526-8209(24)00035.
- SONOLA O
Re: "Diagnostic Delays in Breast Cancer Among Young Women: An Emphasis on
Healthcare Providers" by Costa et al.
Clin Breast Cancer. 2024 Feb 6:S1526-8209(24)00038.
- YOU YH, Kim MK, Lee JY
Prognosis and Adjusting Factors in Elderly Patients With Triple-Negative Breast
Cancer: Comparing With Young and Middle Age Groups.
Clin Breast Cancer. 2024 Jan 30:S1526-8209(24)00027.
- KAVISHAHI NN, Rezaee A, Jalalian S
The Impact of miRNAs on the Efficacy of Tamoxifen in Breast Cancer Treatment: A
Systematic Review.
Clin Breast Cancer. 2024 Jan 26:S1526-8209(24)00026.
- METIN NO, Balci S, Metin Y, Tasci F, et al
Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT
and Prognostic Histopathological Factors and Biomarkers in Breast Cancer.
Clin Breast Cancer. 2024 Feb 1:S1526-8209(24)00037.
Eur J Surg Oncol
- VAN DAM MA, Bijlstra OD, Faber RA, Warmerdam MI, et al
Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course
on fluorescence-guided surgery.
Eur J Surg Oncol. 2024;50:107317.
- SKJERVEN HK, Myklebust EM, Korvald C, Stubberud K, et al
Long-term follow-up of complex oncoplastic breast-conserving surgery, standard
breast conservation and skin-sparing mastectomy in DCIS - a register-based study.
Eur J Surg Oncol. 2024;50:107938.
Eur Radiol
- KOCH HW, Larsen M, Bartsch H, Martiniussen MA, et al
How do AI markings on screening mammograms correspond to cancer location? An
informed review of 270 breast cancer cases in BreastScreen Norway.
Eur Radiol. 2024 Feb 23. doi: 10.1007/s00330-024-10662.
Exp Cell Res
- SHI X, Sun Y, Zhang Y, Wang W, et al
Corrigendum to "MEX3A promotes development and progression of breast cancer
through regulation of PIK3CA" [Exp. Cell Res. 2021 Jul 1;404(1):112580. Epub 2021
Apr 1.].
Exp Cell Res. 2024;436:113964.
Int J Oncol
- MBUGUA RW, Takano A, Tsevegjav B, Yokose T, et al
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target
for breast cancer.
Int J Oncol. 2024;64:43.
Int J Radiat Oncol Biol Phys
- GRENDAROVA P, Roumeliotis M, Quirk S, Phan T, et al
Accelerated Partial Breast Irradiation Using 5 Daily Fractions: A Prospective,
Phase 2, Multicenter Trial of Cosmetic Outcomes and Toxicity-ACCEL Final Results.
Int J Radiat Oncol Biol Phys. 2024;118:1041-1048.
- LAUGHLIN BS, Corbin KS, Toesca DAS, Thorpe CS, et al
Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of
Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation
Therapy After Breast-Conserving Surgery.
Int J Radiat Oncol Biol Phys. 2024;118:1049-1059.
- SILVERWOOD S, Lichter K, Conway A, Drew T, et al
Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic
Review.
Int J Radiat Oncol Biol Phys. 2024;118:891-899.
J Clin Oncol
- WORIAX HE, Thomas SM, Plichta JK, Rosenberger LH, et al
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in
Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant
Chemotherapy.
J Clin Oncol. 2024 Feb 23:JCO2301199. doi: 10.1200/JCO.23.01199.
-
Erratum: Pathologic Exploration of the Axillary Soft Tissue Microenvironment and
Its Impact on Axillary Management and Breast Cancer Outcomes.
J Clin Oncol. 2024 Feb 23:JCO2400317. doi: 10.1200/JCO.24.00317.
- MAXWELL KN, Domchek SM
Toward Application of Polygenic Risk Scores to Both Enhance and Deintensify
Breast Cancer Screening.
J Clin Oncol. 2024 Feb 29:JCO2400029. doi: 10.1200/JCO.24.00029.
- BARDIA A, Rugo HS, Tolaney SM, Loirat D, et al
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic
Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal
Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression.
J Clin Oncol. 2024 Feb 29:JCO2301409. doi: 10.1200/JCO.23.01409.
- MARS N, Kerminen S, Tamlander M, Pirinen M, et al
Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in
Women.
J Clin Oncol. 2024 Feb 29:JCO2300295. doi: 10.1200/JCO.23.00295.
J Natl Cancer Inst
- LI JL, McClellan JC, Zhang H, Gao G, et al
Multi-tissue transcriptome-wide association studies identified 235 genes for
intrinsic subtypes of breast cancer.
J Natl Cancer Inst. 2024 Feb 23:djae041. doi: 10.1093.
Lancet Oncol
- TOI M, Kinoshita T, Benson JR, Jatoi I, et al
Non-surgical ablation for breast cancer: an emerging therapeutic option.
Lancet Oncol. 2024;25:e114-e125.
Mod Pathol
- DERAKHSHAN F, Da Cruz Paula A, Selenica P, da Silva EM, et al
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic
Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Mod Pathol. 2024;37:100375.
- SHAFIQUE A, Gonzalez R, Pantanowitz L, Tan PH, et al
A Preliminary Investigation into Search and Matching for Tumor Discrimination in
World Health Organization Breast Taxonomy Using Deep Networks.
Mod Pathol. 2024;37:100381.
NPJ Breast Cancer
- ALKHAFAJI S, Wolf DM, Magbanua MJM, J van 't Veer L, et al
Circulating tumor cells in early lobular versus ductal breast cancer and their
associations with prognosis.
NPJ Breast Cancer. 2024;10:17.
- LIU H, Xie X, Wang B
Deep learning infers clinically relevant protein levels and drug response in
breast cancer from unannotated pathology images.
NPJ Breast Cancer. 2024;10:18.
Oncogene
- BARRA J, Crosbourne I, Roberge CL, Bossardi-Ramos R, et al
DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron
translocation and metastatic outgrowth.
Oncogene. 2024;43:650-667.
- ZHENG XQ, Guo JP, Yang H, Kanai M, et al
Retraction Note: Aurora-A is a determinant of tamoxifen sensitivity through
phosphorylation of ERalpha in breast cancer.
Oncogene. 2024 Feb 23. doi: 10.1038/s41388-024-02983.
- YANG L, Wang M, Wang Y, Zhu Y, et al
LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin
resistance.
Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02972.
- PRADEEP C-, Zeisel A, Kostler WJ, Lauriola M, et al
Correction: Modeling invasive breast cancer: growth factors propel progression of
HER2-positive premalignant lesions.
Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02990.
Oncology
- ZAVESKY L, Jandakova E, Weinberger V, Minar L, et al
Human endogenous retroviruses (HERVs) in breast cancer: altered expression
pattern implicates divergent roles in carcinogenesis.
Oncology. 2024 Feb 26. doi: 10.1159/000538021.
PLoS One
- KUO ET, Kuo C, Lin CL
Inhaled anesthesia associated with reduced mortality in patients with stage III
breast cancer: A population-based study.
PLoS One. 2024;19:e0289519.
- NYAMHANGA T, Eustace RW, Makoye JP, Mutalemwa K, et al
Multi-level barriers to early detection of breast cancer among rural midlife
women in Tanzania: A qualitative case study.
PLoS One. 2024;19:e0297798.
- MILLER JL, Reddy A, Harman RM, Van de Walle GR, et al
A xenotransplantation mouse model to study physiology of the mammary gland from
large mammals.
PLoS One. 2024;19:e0298390.
- XIA Q, Shen J, Wang Q, Chen R, et al
Cuproptosis-associated ncRNAs predict breast cancer subtypes.
PLoS One. 2024;19:e0299138.
- BAKER R, Dell'Acqua G, Richards A, Thornton MJ, et al
Nutraceuticals known to promote hair growth do not interfere with the inhibitory
action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
PLoS One. 2024;19:e0297080.
- WIRANATA JA, Hutajulu SH, Astari YK, Leo B, et al
Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced
toxicity in patients with early breast cancer.
PLoS One. 2024;19:e0298928.
- TAOMA K, Ruengjitchatchawalya M, Liangruksa M, Laomettachit T, et al
Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug
synergy.
PLoS One. 2024;19:e0298788.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016